ESC Premium Access

Critical appraisal of the CABANA and CASTLE-AF trials.

Congress Session

About the speaker

Professor Isabelle C Van Gelder

University Medical Center Groningen, Groningen (Netherlands (The))
39 presentations

3 more presentations in this session

Effects of atrial fibrillation ablation in patients with stroke risk factors: the CABANA Trial.

Speaker: Doctor D. Packer (Rochester, US)


Effects of atrial fibrillation ablation in patients with lV dysfunction: the CASTE-AF trial.

Speaker: Professor J. Brachmann (Coburg, DE)


Will the technical improvements in atrial fibrillation ablation further improve the success of atrial fibrillation ablation.

Speaker: Professor G. Hindricks (Leipzig, DE)


Access the full session

Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?

Speakers: Professor I. Van Gelder, Doctor D. Packer, Professor J. Brachmann, Professor G. Hindricks

About the event


ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Related content

ESC Premium Access

Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial

27 August 2021

This platform is supported by

logo Novo Nordisk